-Outlook Scientist and longtime activist against genetically modified BT seeds, Dr. Vandana Shiva, talks about why BT has a devastating fallout. A sudden pest attack has ruined cotton crops in large parts of Punjab, bringing biotech, or BT Cotton back into focus. Farmers who used bio-fertilisers in the Malwa region of the state are said to be safe from this latest pestilence. But those growing BT cotton have lost everything. There...
More »SEARCH RESULT
Total Matching Records found : 273
India to supply generic cancer drug to US -Chidanand Rajghatta
-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...
More »Indians face risk from unproven drugs: Lancet -Rupali Mukherjee
-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...
More »Soon, cancer medicines, stents to be cheaper -Sushmi Dey
-The Times of India NEW DELHI: Cancer medicines and stents may soon be available at a substantially lower price. The health ministry is working on a model to procure such drugs in bulk at a negotiated price and supply them to hospitals and consumers through its own retail system like 'Jan Aushadhi' stores. . The idea is to bring down prices of expensive cancer drugs and stents while not putting pressure on...
More »Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey
-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...
More »
